Current Studies

As part of our commitment to be a leader in women’s health care, we continually conduct clinical research studies to advance treatment methods and to identify the most effective means to care for patients.We want to be on the cutting edge of medicine and contribute, first-hand, to benefit not only Rosemark patients but also patients around the world. Rosemark Clinical Research is now enrolling participants in investigational drug studies in the following areas:

Recurrent Yeast Infection

Recurrent vulvovaginal candidiasis (RVVC), also known as recurrent yeast infections, is defined as at least 3 episodes of acute VVC in the past 12 months. Several properties of VT-1161 suggest it might be a safer and more effective treatment of RVVC than other oral antifungal medications. Enroll

Endometriosis Study MT-2990

The purpose of this study is to assess the safety and efficacy of MT- 2990 for treatment of moderate to severe endometriosis-related pain in women with surgically diagnosed endometriosis. Enroll

FemBloc Contraception

Seeking subjects who want permanent birth control Enroll

Uterine Fibroid

The primary objective of this study is to demonstrate the superior efficacy versus placebo of OBE2109 alone and in combination with add-back therapy for the reduction of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Info

Hot Flash

Seeking subjects with moderate to severe hot flashes associated with menopause Info

Can’t find a study that works for you?

Click Here for More Information